Varex Imaging (VREX) Returns To Quarterly Profit And Tests Bearish Margin Narratives
Varex Imaging (VREX) reported a return to quarterly profit in Q1 2026 with a basic EPS of US$0.06, contrasting its trailing 12-month net loss of US$67.7 million. Despite modest 3.4% revenue growth, the company faces scrutiny over earning stability and interest coverage, fueling both bearish concerns about long-term earnings and bullish arguments pointing to a significant valuation gap and analyst price targets.
Varex Imaging Corporation (NASDAQ:VREX) Q2 2026 Earnings Call Transcript
Varex Imaging Corporation reported its Q2 2026 earnings, with revenues of $216 million, non-GAAP gross margin of 34%, and non-GAAP EPS of $0.21, missing expectations slightly. The company saw solid performance in both Medical and Industrial segments, driven by CT sales and demand for nondestructive inspection applications, respectively. Varex also successfully refinanced its debt, strengthening its balance sheet, and provided annual revenue guidance of $860 million to $880 million and non-GAAP EPS of $0.80 to $1 for fiscal year 2026.
Varex Imaging Balances Margin Resilience With Slow Growth
Varex Imaging (VREX) reported Q2 revenue in line with guidance, showing a 1% year-over-year increase, alongside resilient non-GAAP margins and successful debt refinancing. Despite moderate growth and a GAAP loss, the company is investing in technology and manufacturing, with a focus on CT and photon-counting technologies and a new India manufacturing facility expected to improve margins. Varex reinstated annual guidance, signaling anticipated gradual improvement, though it acknowledges ongoing pressure from a sluggish market, higher operating expenses, and input cost inflation.
Varex Imaging (VREX) Q2 2026 Earnings Transcript
Varex Imaging (VREX) reported solid Q2 2026 results with total revenue up 1% to $216 million, driven by growth in both Medical and Industrial segments, and non-GAAP EPS of $0.21. The company successfully executed a debt refinancing, strengthening its capital structure and reducing interest expenses. Varex reinstated annual guidance, projecting full-year revenue of $860 million-$880 million and non-GAAP EPS of $0.80-$1.00, while continuing to invest in advanced imaging technologies and industrial applications, including photon counting and cargo security systems.
Varex outlines FY2026 revenue of $860M-$880M and non-GAAP EPS of $0.80-$1.00 while shifting to annual guidance
Varex Imaging Corporation has provided its financial guidance for fiscal year 2026, projecting revenues between $860 million and $880 million and non-GAAP EPS in the range of $0.80 to $1.00. This announcement marks a shift from quarterly to annual guidance, reflecting the company's expected recovery and growth, particularly in its Medical and Industrial segments. The company anticipates a gradual ramp-up in its X-ray detector business, especially with new product introductions and stabilizing inventory levels.
Varex Imaging Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VREX)
Varex Imaging Corporation (NASDAQ:VREX) reported its Q2 2026 earnings, with an EPS of $0.21, which beat estimates, and revenue of $216.00M, missing expectations by $920K. The company published a slide deck in conjunction with its earnings call. This article provides access to the earnings summary, insights, and transcript for investors.
Varex Imaging Net Sales Rise to $226 Million in Second Quarter of Fiscal Year 2026
Varex Imaging Corporation announced its financial results for the second quarter of fiscal year 2026, reporting net sales of $226 million, an increase from $218 million in the prior year. Despite a slight decrease in gross margin from 30.8% to 30.3%, the company saw its net income rise to $16 million from $14 million. Operating expenses also increased to $53 million from $51 million.
Varex Announces Financial Results for Second Quarter Fiscal Year 2026
Varex Imaging Corporation announced its Q2 FY26 financial results, with revenues of $216 million, driven by solid demand in Medical and Industrial businesses. The company reported a GAAP net loss of $0.19 per diluted share and a non-GAAP net income of $0.21 per diluted share, with cash outflows from operations of $2 million. Varex expects revenue to be up approximately 3% in the second half of fiscal 2026, with full fiscal year 2026 revenue projected between $860 million and $880 million.
Varex Imaging (VREX) swings to Q2 loss, sets 2026 revenue and EPS guidance
Varex Imaging Corporation reported a Q2 fiscal 2026 revenue of $216 million, a 1% increase year-over-year, but still swung to a GAAP net loss of $0.19 per diluted share. Despite solid demand in both medical and industrial segments, lower margins and higher interest costs impacted profitability. The company expects full fiscal year 2026 revenue between $860 million and $880 million and non-GAAP EPS between $0.80 and $1.00.
Precision Trading with Varex Imaging Corporation (VREX) Risk Zones
This article analyzes Varex Imaging Corporation (VREX), highlighting strong sentiment across all time horizons and an exceptional 59.7:1 risk-reward setup targeting a 15.6% gain against a 0.3% risk. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, complete with entry zones, target prices, and stop losses. The analysis also provides multi-timeframe signal analysis, including support and resistance levels.
X-ray imaging maker Varex will post quarterly results after May 7 close
Varex Imaging Corporation (Nasdaq: VREX) announced it will report unaudited financial results for the second quarter of fiscal year 2026 after the close of regular trading on Thursday, May 7, 2026. A conference call will follow the earnings release at 3:00 pm Mountain Time, accessible via webcast on the company's website or by phone. The webcast and a replay will be available for investors.
Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation announced it will release its unaudited financial results for the second quarter of fiscal year 2026 after market close on Thursday, May 7, 2026. This will be followed by a conference call at 3:00 pm Mountain Time the same day to discuss the results. The company provides details on how to access the webcast and conference call, along with replay information.
Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation (Nasdaq: VREX) announced it will release its unaudited financial results for the second quarter of fiscal year 2026 after the market closes on Thursday, May 7, 2026. This will be followed by a conference call at 3:00 pm Mountain Time on the same day, which will be webcast live on the company's website. Investors can access the call via phone or find an archived replay on the website until May 21st.
Wall Street Analysts See a 57.62% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High?
Shares of VAREX IMAGING (VREX) have seen a 2.5% gain, closing at $11.42, with Wall Street analysts projecting a potential upside of 57.6% based on a mean price target of $18. This optimism is further supported by a positive trend in earnings estimate revisions and a Zacks Rank #1 (Strong Buy) rating. While price targets should be treated with skepticism due to potential analyst biases, the consistent upward revision of earnings estimates suggests genuine potential for stock appreciation.
Technical Reactions to VREX Trends in Macro Strategies
This article analyzes Varex Imaging Corporation (NASDAQ: VREX) using AI models, identifying near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It highlights elevated downside risk due to a lack of long-term support signals. The analysis provides three distinct institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
Varex Imaging to redeem $368 million of 7.875% senior secured notes due 2027
Varex Imaging Corporation has announced its intention to redeem $368 million of its outstanding 7.875% Senior Secured Notes due 2027. The redemption is expected to take place on May 15, 2026, at a price of 103.938% of the principal amount, plus accrued and unpaid interest. This move aims to optimize the company's capital structure.
JPMorgan Chase & Co. Acquires 225,238 Shares of Varex Imaging $VREX
JPMorgan Chase & Co. significantly increased its stake in Varex Imaging (NASDAQ:VREX) by 381.8% in the third quarter, acquiring an additional 225,238 shares to own a total of 284,227 shares valued at approximately $3.52 million. This move makes JPMorgan Chase & Co. a 0.68% shareholder in the company. The article also notes mixed analyst ratings for Varex, with a consensus "Hold" rating and a $16.17 average target price, following the company's Q1 earnings beat and Q2 2026 guidance.
VREX Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and event updates for Varex Imaging (VREX), including a new credit agreement, investor conference presentations, and senior secured notes redemption. Key financial announcements detail Q1 2026 revenue exceeding expectations at $210 million, driven by strength in cargo systems, and a Q2 revenue outlook of $210M to $225M. Analyst predictions also suggest a potential 29.92% rise for VREX.
VREX Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Varex Imaging Corp (VREX), indicating a "Strong Sell" consensus based on various technical indicators. The analysis covers moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The stock is currently trading below its 200-day moving average, reinforcing the bearish sentiment.
Trading the Move, Not the Narrative: (VREX) Edition
This article provides an AI-generated analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting divergent sentiment across different time horizons and suggesting choppy conditions. It presents three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to various risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes trading the move rather than the narrative, leveraging institutional-grade predictive AI.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Varex Imaging Corp (VREX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It details recent filings such as a 10-Q quarterly earnings report, Pzena Investment's increased ownership to over 10%, and a director's stock sale. The platform offers AI-powered summaries to help investors quickly grasp key information from these regulatory documents.
Varex Imaging (VREX) SVP Jesse Merkley reports shares, RSUs, PSUs and options
Varex Imaging Corp's SVP and GM, Industrial, Jesse Don Merkley, filed an initial ownership report detailing his equity holdings in the company. The report indicates he directly holds 15,334 shares of common stock, alongside various equity awards including restricted stock units (RSUs), performance stock units (PSUs), and a non-qualified stock option for 9,727 shares. These awards are subject to vesting schedules and performance conditions, demonstrating a comprehensive equity compensation structure for the executive.
Varex Imaging Corp (NASDAQ: VREX) — Vanguard files amendment showing 0% ownership
The Vanguard Group filed an amended Schedule 13G/A for Varex Imaging Corp (VREX), reporting 0 shares beneficially owned, representing 0% of the class. This amendment follows an internal realignment at Vanguard effective January 12, 2026, which prompted subsidiaries to report their holdings separately. The filing confirms that The Vanguard Group itself no longer retains beneficial ownership over these securities, with future filings expected from disaggregated entities.
Varex Imaging (VREX) SVP Garcia details stock, RSU and option holdings
Varex Imaging Corp's Senior Vice President of Regulatory and Quality Assurance, Victor Hugo Garcia, filed a Form 3 detailing his equity holdings in the company. The filing indicates direct ownership of 23,360 shares of common stock, in addition to various restricted stock units, performance stock units, and non-qualified stock options. These holdings represent Garcia's existing stake and not new open-market transactions.
Varex Imaging (VREX) director sells 4,510 shares, keeps 23,450
Varex Imaging Corp director Jay K. Kunkel sold 4,510 shares of common stock at $11.14 per share in an open-market transaction on March 20, 2026. Following this sale, Kunkel directly holds 23,450 shares, maintaining a significant equity stake in the company. The transaction was filed as a Form 4 with the SEC.
Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp Ahead
Varex Imaging (NASDAQ:VREX) reports steady demand despite geopolitical events, with healthcare and industrial markets remaining stable, and security-related inquiries increasing. The company anticipates modest gross margin improvements from tariff relief and is pursuing supply chain diversification. Key growth drivers include manufacturing expansion in India, development of photon-counting CT detectors, and growth in cargo inspection systems, alongside interest savings from a recent debt refinancing.
Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp Ahead
Varex Imaging reported stable demand despite geopolitical events and tariff volatility, noting healthcare and non-destructive testing are largely unaffected, while security-related inquiries are rising. The company anticipates modest gross margin improvements as higher-tariff inventory clears, and expects significant growth from India manufacturing expansion, photon-counting CT detectors, cargo inspection systems, and recent debt refinancing. These initiatives are projected to boost revenue, profitability, and annual EPS.
VREX (NASDAQ: VREX) files Rule 144 notice listing 4,510 vested shares
Varex Imaging Corp (NASDAQ: VREX) has filed a Rule 144 notice for the proposed sale of 4,510 vested common shares through Fidelity Brokerage Services LLC. The filing details two tranches of restricted stock vesting: 875 shares on February 13, 2023, and 3,635 shares on February 11, 2024. This administrative disclosure does not specify sale timing or methods but provides information on the shares for sale the broker, and the market (NASDAQ).
Form 144 Varex Imaging Corp For: 20 March
This article announces the filing of Form 144 by Varex Imaging Corp for March 20. It includes standard disclaimers about the risks associated with trading financial instruments and cryptocurrencies, emphasizing that the provided data may not be real-time or accurate. The content advises potential investors to seek professional advice and be aware of the high risks involved in trading.
Form 144 Varex Imaging Corp For: 20 March
This article announces the filing of Form 144 for Varex Imaging Corp on March 20. It provides this information without further detail, likely serving as a routine financial market update. The page also includes broader market data and other news headlines.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Varex Imaging Corp (VREX) SEC filings, including annual 10-K, quarterly 10-Q, and material 8-K reports, as well as insider trading forms. It details Varex's business in X-ray imaging components and systems, offering insights into financial performance, risk factors, and governance. The platform also features AI-powered summaries of these documents and tracks insider activity.
Varex Imaging Refinances Debt With New Credit Facility
Varex Imaging has refinanced its debt by entering into a new $490 million secured credit facility maturing in 2031, which allowed it to redeem its existing 7.875% Senior Secured Notes due 2027. This move is expected to reduce annual cash interest expense by over $7 million and enhance financial flexibility. Despite strong revenue growth, Spark, TipRanks' AI Analyst, rates VREX as Neutral due to weakened financial performance.
Varex Imaging: $490 Million Credit Facility Refinancing To Strengthen Balance Sheet And Lower Interest Costs
Varex Imaging has completed a $490 million debt refinancing, consisting of a $350 million term loan, a $100 million revolving facility, and a $40 million delayed draw term loan, all maturing in March 2031. This refinancing allowed the company to redeem its high-interest notes and is projected to reduce annual cash interest expenses by over $7 million. The move is expected to improve financial flexibility, enhance free cash flow, and support continued investment in its core business.
Varex’s new $490M loan deal aims to save over $7M a year in interest
Varex Imaging Corporation has completed a debt refinancing by entering a new Credit and Guaranty Agreement for $490 million, replacing its previous credit facility and redeeming existing Senior Secured Notes. This move is expected to reduce the company's annualized cash interest expense by over $7 million, improve financial flexibility, and support free cash flow generation. The new credit facility includes a secured term loan, a revolving credit facility, and a delayed draw term loan.
Varex Imaging Announces $490 Million Debt Refinancing to Reduce Interest Expense and Strengthen Balance Sheet
Varex Imaging Corporation has completed a $490 million debt refinancing, entering into a new Credit Facility to replace its previous arrangements. This move includes a $350 million secured term loan, a $100 million revolving credit facility, and a $40 million delayed draw term loan, all maturing in March 2031. The refinancing is expected to reduce annualized cash interest expense by over $7 million and strengthen the company's balance sheet, improving financial flexibility and free cash flow generation.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Varex Imaging Corporation (VREX) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event reports (8-K), and insider trading forms. It highlights recent insider trading activities with detailed summaries from Form 4 filings, showing conversions of deferred stock units into common shares by various directors and performance stock unit updates for executives. The article explains how the platform offers AI-powered summaries to help investors quickly understand key financial and governance disclosures.
Varex Imaging Secures $490 Million Credit Facilities to Refinance 2027 Notes
Varex Imaging has secured new credit facilities totaling $490 million, including a $350 million term loan, $100 million revolver, and $40 million delayed draw term loan. The company used $350 million from this agreement to fully redeem its 7.875% Senior Secured Notes due 2027 and terminated its previous $155 million revolving credit agreement. These actions aim to streamline Varex's capital structure, reduce debt costs, and enhance liquidity.
Varex Imaging (Nasdaq: VREX) trims debt and locks in $490M credit to 2031
Varex Imaging Corporation has refinanced its debt by securing a new $490 million Credit and Guaranty Agreement, comprising a $350 million secured term loan, a $100 million secured revolving credit facility, and a $40 million secured delayed draw term loan, all maturing in March 2031. This refinancing allowed the company to redeem its $368 million 7.875% Senior Secured Notes due 2027, reducing outstanding debt by $18 million and is expected to save over $7 million in annual cash interest expense. The new credit facility includes SOFR-based variable interest, with an interest rate swap fixing the SOFR component at 3.65% to provide more predictable funding costs.
Varex Announces Successful Completion of Debt Refinancing
Varex Imaging Corporation announced the successful completion of a debt refinancing, entering into a new Credit and Guaranty Agreement totaling $490 million. This new facility allowed the company to redeem its outstanding $368 million 7.875% Senior Secured Notes due 2027 and terminate its previous revolving credit facility. The refinancing is expected to strengthen Varex's balance sheet, reduce interest expenses by over $7 million annually, and improve financial flexibility.
Price-Driven Insight from (VREX) for Rule-Based Strategy
Quantitative Research Desk provides an AI-driven analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting weak near and mid-term sentiment but a strong long-term outlook. The report offers three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. It also details multi-timeframe signal analysis indicating support and resistance levels for different time horizons.
Varex Management to Present in Upcoming Investor Conferences
Varex Imaging Corporation announced that its management is scheduled to present at two upcoming investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference on Tuesday, March 17, 2025, and the Sidoti Small Cap Virtual Conference on Wednesday, March 18, 2026. Webcast links for both presentations are available on Varex's website. Varex is a leading designer and manufacturer of X-ray imaging components used in medical, industrial, and security applications.
Varex Management to Present in Upcoming Investor Conferences
Varex Imaging Corporation announced that its management is scheduled to present at two upcoming investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference on March 17, 2025, and the Sidoti Small Cap Virtual Conference on March 18, 2026. Webcast links for both presentations are available on Varex’s website. The company specializes in X-ray imaging components for medical, industrial, and security applications.
Varex investor webcasts set for Oppenheimer and Sidoti conferences
Varex Imaging Corporation (Nasdaq: VREX) announced that its management is scheduled to present at two upcoming virtual investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Conference on March 17, 2025, and the Sidoti Small Cap Virtual Conference on March 18, 2026. Webcasts for both events will be accessible via Varex's website. Varex is a leading designer and manufacturer of X-ray imaging components for medical, industrial, and security applications.
VREX Earnings History & Surprises | EPS & Revenue Results | VAREX IMAGING CORP (NASDAQ:VREX)
This article provides a comprehensive overview of VAREX IMAGING CORP (VREX) earnings history, including past quarterly EPS and revenue results, analyst estimates, and surprise percentages. It details upcoming earnings dates and offers an analysis of beat rates over the last four quarters, highlighting consistent EPS beats and frequent revenue beats. The report also includes graphical representations of EPS and revenue quarter-over-quarter growth trends.
Varex Imaging Corporation to redeem its 7.875% senior secured notes due 2027
Varex Imaging Corporation announced its intention to redeem its 7.875% senior secured notes due 2027. The company's stock, VREX, closed at 11.40 USD with a recent decrease. Analysts currently have an average target price of 18.40 USD for Varex Imaging.
Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027
Varex Imaging Corporation announced its conditional full redemption of all outstanding 7.875% senior secured notes due October 15, 2027, totaling $368 million, on March 16, 2026. The redemption is conditional upon securing new financing to fund the payment of $1,052.72125 per $1,000 principal amount. If the financing condition is not met, the redemption may be delayed or terminated.
Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027
Varex Imaging Corporation announced its conditional full redemption of all outstanding 7.875% senior secured notes due October 15, 2027, on March 16, 2026. The redemption is contingent upon the funding of a new credit facility and cash on hand. The company, a leading innovator in X-ray imaging components, emphasizes that this press release is for informational purposes only and does not constitute a notice of redemption or an offer to sell securities.
Varex Imaging Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals
Varex Imaging Corp. has revised its stock evaluation, currently priced at $12.58, showing mixed technical indicators despite some positive momentum. The company, a microcap player in Pharmaceuticals & Biotechnology, has faced market challenges, underperforming the S&P 500 over several periods, particularly in the long term. This highlights its ongoing struggles within a competitive market.
VREX Financials: Income Statement, Balance Sheet & Cash Flow
This article provides an in-depth financial analysis of Varex Imaging Corp (VREX), detailing its income statement, balance sheet, and cash flow statement for annual and quarterly periods. It also evaluates key financial health indicators such as profitability, growth, leverage, liquidity, and cash flow, along with an F-Score and earnings quality assessment. The report highlights that VREX generated $844.6M in revenue in FY2025 but reported a net income loss of -$70.3M and has an "at risk" interest coverage ratio.
Varex Imaging (NASDAQ:VREX) Upgraded at Wall Street Zen
Wall Street Zen has upgraded Varex Imaging (NASDAQ:VREX) from a "buy" to a "strong-buy" rating. This upgrade is part of a mixed analyst sentiment, resulting in a consensus "Hold" rating and a target price of $16.17 for the company. Varex Imaging recently exceeded quarterly earnings and revenue expectations and has provided Q2 2026 guidance.
